VIRAGEN  VRGN STARTS HUMAN TRIALS HIALEAH FLA MARCH 11 VIRAGEN INC SAID IT IS SPONSORING CLINICAL STUDIES OF HUMAN LEUKOCYTE INTERFERON ALPHA IN THE TREATMENT OF RENAL CELL CARCINOMA AND BLADDER CELL CARCINOMA THE FOOD AND DRUG ADMINISTRATION APPROVED HUMAN TRIALS  WILL BE CONDUCTED ON AT LEAST 30 PATIENTS MALE AND FEMALE FOR EACH CANCER TYPE   